Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Outlook Therapeutics Inc. buy Warner

Start price
€1.25
13.11.25 / 0%
Target price
-
13.11.26
Performance (%)
21.74%
Price
€1.52
17.11.25
Summary
This prediction is currently active. The BUY prediction by Warner currently has a performance of 21.74%. This prediction currently runs until 13.11.26. The prediction end date can be changed by Warner at any time. This prediction was marked as speculative and is excluded from Warner's performance statistics.
Performance without dividends (%)
Name 1w
Outlook Therapeutics Inc. 21.74%
iShares Core DAX® -2.597%
iShares Nasdaq 100 -3.356%
iShares Nikkei 225® -4.112%
iShares S&P 500 -2.520%

According to Warner what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Little innovation

Comments by Warner for this prediction

In the thread Outlook Therapeutics Inc. diskutieren

Buy Outlook Therapeutics Inc.

Stopped prediction by Warner for Outlook Therapeutics Inc.

buy
Outlook Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.85
27.11.24
-
27.11.25
112.94%
03.12.24

Could be worthwhile Investment >10% per year
Capable Management
Little innovation